VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 103 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,627 | -33.0% | 20,468 | -33.3% | 0.00% | -100.0% |
| Q1 2023 | $236,728 | +84.1% | 30,704 | +45.7% | 0.00% | – |
| Q4 2022 | $128,570 | -18.1% | 21,077 | +2.3% | 0.00% | -100.0% |
| Q1 2022 | $157,000 | +93.8% | 20,602 | +19.8% | 0.00% | – |
| Q1 2021 | $81,000 | -90.8% | 17,200 | -86.1% | 0.00% | -100.0% |
| Q4 2020 | $882,000 | -32.7% | 123,360 | +0.4% | 0.00% | -20.0% |
| Q3 2020 | $1,311,000 | -16.9% | 122,860 | -1.7% | 0.01% | -37.5% |
| Q2 2020 | $1,577,000 | +25.9% | 124,960 | -8.7% | 0.01% | 0.0% |
| Q1 2020 | $1,253,000 | -23.9% | 136,938 | +16.1% | 0.01% | +60.0% |
| Q4 2019 | $1,646,000 | +43.1% | 117,963 | +76.6% | 0.01% | +25.0% |
| Q3 2019 | $1,150,000 | +995.2% | 66,800 | +499.6% | 0.00% | – |
| Q4 2018 | $105,000 | -57.1% | 11,141 | -13.9% | 0.00% | -100.0% |
| Q3 2018 | $245,000 | – | 12,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
| Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
| Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
| ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
| Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
| PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
| Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
| Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
| 361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
| Birchview Capital, LP | 30,000 | $516,000 | 0.34% |